enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Bimekizumab - Wikipedia

   en.wikipedia.org/wiki/Bimekizumab

   Bimekizumab, sold under the brand name Bimzelx, is a humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody [6] [7] that is used to treat plaque psoriasis, psoriatic arthritis, axial spondyloarthritis, ankylosing spondylitis and hidradenitis suppurativa.

3. Acitretin - Wikipedia

   en.wikipedia.org/wiki/Acitretin

   Acitretin, sold under the brand names Neotigason [2] and Soriatane, [5] is a second-generation retinoid.It is taken orally, and is typically used for psoriasis. [6]Acitretin is an oral retinoid used in the treatment of severe resistant psoriasis.

4. Spesolimab - Wikipedia

   en.wikipedia.org/wiki/Spesolimab

   Spesolimab, sold under the brand name Spevigo, is a monoclonal antibody used for the treatment of generalized pustular psoriasis (GPP). [4] It is an interleukin-36 receptor (IL-36R) antagonist. [4] [6] It is given via injection into a vein. [4] [6]

5. Deucravacitinib - Wikipedia

   en.wikipedia.org/wiki/Deucravacitinib

   Deucravacitinib, sold under the brand name Sotyktu, is a medication used for the treatment of moderate-to-severe plaque psoriasis. [7] It is a tyrosine kinase 2 (TYK2) inhibitor and it is taken by mouth. [7]

6. Psoriasis - Wikipedia

   en.wikipedia.org/wiki/Psoriasis

   Mercury was also used for psoriasis treatment during this time. [134] Sulfur, iodine, and phenol were also commonly used treatments for psoriasis during this era when it was incorrectly believed that psoriasis was an infectious disease. [134] Coal tars were widely used with ultraviolet light irradiation as a topical treatment approach in the ...

7. Understanding The Power Of Light Therapy For Psoriasis - AOL

   www.aol.com/news/understanding-power-light...

   Psoriasis occurs when a person's immune system becomes overactive, leading to the rapid multiplication of their skin cells. This results in scaly, inflamed patches of skin, most likely on the ...